SCHEMBL29652138

SCHEMBL29652138

N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NPY4R P50391 16/20 0.63
NPY1R P25929 10/20 0.63
NPY5R Q15761 7/20 0.63
NPY2R P49146 6/20 0.63
GNPAT O15228 1/20 0.51
KISS1R Q969F8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29652147 1.00 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL29652153 1.00 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL29370061 1.00 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL30046023 0.99 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL29800135 0.99 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL29652151 0.98 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL10940118 0.98 NPY4R (0.60) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL29666714 0.98 NPY4R (0.60) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL31184527 0.97 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2RGNPAT
SCHEMBL4048021 0.97 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2RGNPAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240084068-A1 POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF GENEPEP (FR) 2024-03-14 US claimed
WO-2022128940-A1 POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF GENEPEP (FR) 2022-06-23 WO claimed
EP-4011932-A1 POLYMER COMPOUND WITH PENDANT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF Genepep (FR) 2022-06-15 EP claimed
US-20240084068-A1 POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF GENEPEP (FR) 2024-03-14 US disclosed
WO-2022128940-A1 POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF GENEPEP (FR) 2022-06-23 WO disclosed
EP-4011932-A1 POLYMER COMPOUND WITH PENDANT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF Genepep (FR) 2022-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240084068-A1 POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF VIP, PSAP, NGLY1 NPY4R 935/4885NPY1R 914/4885NPY5R 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.